{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:47:27Z","timestamp":1791283647826,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T00:00:00Z","timestamp":1211932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00702-008-0067-y","type":"journal-article","created":{"date-parts":[[2008,5,27]],"date-time":"2008-05-27T05:01:10Z","timestamp":1211864470000},"page":"1165-1172","source":"Crossref","is-referenced-by-count":47,"title":["Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer\u2019s disease neuropathology"],"prefix":"10.1007","volume":"115","author":[{"given":"Mitchell K. P.","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle G. K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kirvell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasinda","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Esiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,28]]},"reference":[{"key":"67_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281\u2013341","journal-title":"Pharmacol Rev"},{"key":"67_CR2","doi-asserted-by":"crossref","first-page":"19138","DOI":"10.1073\/pnas.0505913102","volume":"102","author":"DB Arthur","year":"2005","unstructured":"Arthur DB, Akassoglou K, Insel PA (2005) P2Y2 receptor activates nerve growth factor\/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 102:19138\u201319143","journal-title":"Proc Natl Acad Sci USA"},{"key":"67_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"DS Auld","year":"2002","unstructured":"Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209\u2013245","journal-title":"Prog Neurobiol"},{"key":"67_CR4","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s007020070021","volume":"107","author":"C Behl","year":"2000","unstructured":"Behl C (2000) Apoptosis and Alzheimer\u2019s disease. J Neural Transm 107:1325\u20131344","journal-title":"J Neural Transm"},{"key":"67_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"67_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"G Burnstock","year":"2007","unstructured":"Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659\u2013797","journal-title":"Physiol Rev"},{"key":"67_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2007.01.053","volume":"562","author":"D Butler","year":"2007","unstructured":"Butler D, Bendiske J, Michaelis ML, Karanian DA, Bahr BA (2007) Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. Eur J Pharmacol 562:20\u201327","journal-title":"Eur J Pharmacol"},{"key":"67_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bjp.0705959","volume":"143","author":"JA Calvert","year":"2004","unstructured":"Calvert JA, Atterbury-Thomas AE, Leon C, Forsythe ID, Gachet C, Evans RJ (2004) Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia. Br J Pharmacol 143:525\u2013532","journal-title":"Br J Pharmacol"},{"key":"67_CR9","doi-asserted-by":"crossref","first-page":"18696","DOI":"10.1074\/jbc.M500219200","volume":"280","author":"JM Camden","year":"2005","unstructured":"Camden JM, Schrader AM, Camden RE, Gonzalez FA, Erb L, Seye CI, Weisman GA (2005) P2Y2 nucleotide receptors enhance \u03b1-secretase-dependent amyloid precursor protein processing. J Biol Chem 280:18696\u201318702","journal-title":"J Biol Chem"},{"key":"67_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yexcr.2004.07.009","volume":"300","author":"F Cavaliere","year":"2004","unstructured":"Cavaliere F, Amadio S, Angelini DF, Sancesario G, Bernardi G, Volonte C (2004) Role of the metabotropic P2Y4 receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor. Exp Cell Res 300:149\u2013158","journal-title":"Exp Cell Res"},{"key":"67_CR11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2004.09.001","volume":"18","author":"F Cavaliere","year":"2005","unstructured":"Cavaliere F, Nestola V, Amadio S, D\u2019Ambrosi N, Angelini DF, Sancesario G, Bernardi G, Volonte C (2005) The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 18:100\u2013109","journal-title":"Neurobiol Dis"},{"key":"67_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(88)90021-2","volume":"452","author":"G Cole","year":"1988","unstructured":"Cole G, Dobkins KR, Hansen LA, Terry RD, Saitoh T (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452:165\u2013174","journal-title":"Brain Res"},{"key":"67_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jnen\/64.4.263","volume":"64","author":"SE Counts","year":"2005","unstructured":"Counts SE, Mufson EJ (2005) The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol 64:263\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"67_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0197-4580(86)90019-9","volume":"7","author":"AJ Cross","year":"1986","unstructured":"Cross AJ, Crow TJ, Ferrier IN, Johnson JA (1986) The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia. Neurobiol Aging 7:3\u20137","journal-title":"Neurobiol Aging"},{"key":"67_CR15","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/00019442-199821001-00009","volume":"6","author":"JL Cummings","year":"1998","unstructured":"Cummings JL, Back C (1998) The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer\u2019s disease. Am J Geriatr Psychiatry 6:S64\u2013S78","journal-title":"Am J Geriatr Psychiatry"},{"key":"67_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.410290305","volume":"29","author":"DD Flynn","year":"1991","unstructured":"Flynn DD, Weinstein DA, Mash DC (1991) Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer\u2019s disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29:256\u2013262","journal-title":"Ann Neurol"},{"key":"67_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/gps.934","volume":"18","author":"PT Francis","year":"2003","unstructured":"Francis PT (2003) Glutamatergic systems in Alzheimer\u2019s disease. Int J Geriatr Psychiatry 18:S15\u2013S21","journal-title":"Int J Geriatr Psychiatry"},{"key":"67_CR19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1471-4159.1993.tb13381.x","volume":"60","author":"PT Francis","year":"1993","unstructured":"Francis PT, Sims NR, Procter AW, Bowen DM (1993) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer\u2019s disease: investigative and therapeutic perspectives. J Neurochem 60:1589\u20131604","journal-title":"J Neurochem"},{"key":"67_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137\u2013147","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"67_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/MN:31:1-3:065","volume":"31","author":"FA Gonzalez","year":"2005","unstructured":"Gonzalez FA, Weisman GA, Erb L, Seye CI, Sun GY, Velazquez B, Hernandez-Perez M, Chorna NE (2005) Mechanisms for inhibition of P2 receptors signaling in neural cells. Mol Neurobiol 31:65\u201379","journal-title":"Mol Neurobiol"},{"key":"67_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01251916","volume":"61","author":"JA Hardy","year":"1985","unstructured":"Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A (1985) The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm 61:253\u2013264","journal-title":"J Neural Transm"},{"key":"67_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(00)00028-5","volume":"393","author":"E Hellstrom-Lindahl","year":"2000","unstructured":"Hellstrom-Lindahl E (2000) Modulation of \u03b2-amyloid precursor protein processing and \u03c4 phosphorylation by acetylcholine receptors. Eur J Pharmacol 393:255\u2013263","journal-title":"Eur J Pharmacol"},{"key":"67_CR24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1074::AID-GPS696>3.0.CO;2-B","volume":"12","author":"T Hope","year":"1997","unstructured":"Hope T, Keene J, Fairburn C, McShane R, Jacoby R (1997a) Behaviour changes in dementia. 2: Are there behavioural syndromes? Int J Geriatr Psychiatry 12:1074\u20131078","journal-title":"Int J Geriatr Psychiatry"},{"key":"67_CR26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1062::AID-GPS675>3.0.CO;2-N","volume":"12","author":"T Hope","year":"1997","unstructured":"Hope T, Keene J, Gedling K, Cooper S, Fairburn C, Jacoby R (1997b) Behaviour changes in dementia. 1: Point of entry data of a prospective study. Int J Geriatr Psychiatry 12:1062\u20131073","journal-title":"Int J Geriatr Psychiatry"},{"key":"67_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/bjp.174.1.39","volume":"174","author":"T Hope","year":"1999","unstructured":"Hope T, Keene J, Fairburn CG, Jacoby R, McShane R (1999) Natural history of behavioural changes and psychiatric symptoms in Alzheimer\u2019s disease. A longitudinal study. Br J Psychiatry 174:39\u201344","journal-title":"Br J Psychiatry"},{"key":"67_CR27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00424-006-0063-8","volume":"452","author":"S Hussl","year":"2006","unstructured":"Hussl S, Boehm S (2006) Functions of neuronal P2Y receptors. Pflugers Arch 452:538\u2013551","journal-title":"Pflugers Arch"},{"key":"67_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.neuroscience.2005.11.017","volume":"138","author":"EH Jacobs","year":"2006","unstructured":"Jacobs EH, Williams RJ, Francis PT (2006) Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1\/X11\u03b1 protein up-regulation in Alzheimer\u2019s disease. Neuroscience 138:511\u2013522","journal-title":"Neuroscience"},{"key":"67_CR29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0006-2952(02)01614-3","volume":"65","author":"SG Kim","year":"2003","unstructured":"Kim SG, Soltysiak KA, Gao ZG, Chang TS, Chung E, Jacobson KA (2003) Tumor necrosis factor \u03b1-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem Pharmacol 65:923\u2013931","journal-title":"Biochem Pharmacol"},{"key":"67_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","volume":"98","author":"SL Kirvell","year":"2006","unstructured":"Kirvell SL, Esiri M, Francis PT (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer\u2019s disease. J Neurochem 98:939\u2013950","journal-title":"J Neurochem"},{"key":"67_CR31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.57.5.805","volume":"57","author":"MK Lai","year":"2001","unstructured":"Lai MK, Lai OF, Keene J, Esiri MM, Francis PT, Hope T, Chen CP (2001) Psychosis of Alzheimer\u2019s disease is associated with elevated muscarinic M2 binding in the cortex. Neurology 57:805\u2013811","journal-title":"Neurology"},{"key":"67_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-004-2077-2","volume":"179","author":"MK Lai","year":"2005","unstructured":"Lai MK, Tsang SW, Alder JT, Keene J, Hope T, Esiri MM, Francis PT, Chen CP (2005) Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer\u2019s disease. Psychopharmacology (Berl) 179:673\u2013677","journal-title":"Psychopharmacology (Berl)"},{"key":"67_CR33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mad.2005.09.016","volume":"127","author":"A Lanari","year":"2006","unstructured":"Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L (2006) Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer\u2019s disease. Mech Ageing Dev 127:158\u2013165","journal-title":"Mech Ageing Dev"},{"key":"67_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.neuropsych.13.1.5","volume":"13","author":"KL Lanctot","year":"2001","unstructured":"Lanctot KL, Herrmann N, Mazzotta P (2001) Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 13:5\u201321","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"67_CR35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1113\/jphysiol.2007.130377","volume":"581","author":"CJ Lee","year":"2007","unstructured":"Lee CJ, Mannaioni G, Yuan H, Woo DH, Gingrich MB, Traynelis SF (2007) Astrocytic control of synaptic NMDA receptors. J Physiol 581:1057\u20131081","journal-title":"J Physiol"},{"key":"67_CR36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cercor\/bhh200","volume":"15","author":"JP Lerch","year":"2005","unstructured":"Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer\u2019s disease identified by computational neuroanatomy. Cereb Cortex 15:995\u20131001","journal-title":"Cereb Cortex"},{"key":"67_CR37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/neur.1996.0057","volume":"5","author":"DM Mann","year":"1996","unstructured":"Mann DM (1996) Pyramidal nerve cell loss in Alzheimer\u2019s disease. Neurodegeneration 5:423\u2013427","journal-title":"Neurodegeneration"},{"key":"67_CR38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jnr.20487","volume":"81","author":"JG McLarnon","year":"2005","unstructured":"McLarnon JG, Choi HB, Lue LF, Walker DG, Kim SU (2005) Perturbations in calcium-mediated signal transduction in microglia from Alzheimer\u2019s disease patients. J Neurosci Res 81:426\u2013435","journal-title":"J Neurosci Res"},{"key":"67_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(96)02266-8","volume":"87","author":"A Meneses","year":"1997","unstructured":"Meneses A, Hong E (1997) Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning. Behav Brain Res 87:105\u2013110","journal-title":"Behav Brain Res"},{"key":"67_CR40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"67_CR41","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1097\/00001756-200011270-00041","volume":"11","author":"D Moore","year":"2000","unstructured":"Moore D, Iritani S, Chambers J, Emson P (2000) Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer\u2019s disease. Neuroreport 11:3799\u20133803","journal-title":"Neuroreport"},{"key":"67_CR42","first-page":"224","volume":"50","author":"RA Nicholas","year":"1996","unstructured":"Nicholas RA, Watt WC, Lazarowski ER, Li Q, Harden K (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 50:224\u2013229","journal-title":"Mol Pharmacol"},{"key":"67_CR44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.1411529","volume":"258","author":"RM Nitsch","year":"1992","unstructured":"Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304\u2013307","journal-title":"Science"},{"key":"67_CR43","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1074\/jbc.271.8.4188","volume":"271","author":"RM Nitsch","year":"1996","unstructured":"Nitsch RM, Deng M, Growdon JH, Wurtman RJ (1996) Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem 271:4188\u20134194","journal-title":"J Biol Chem"},{"key":"67_CR45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/REVNEURO.1989.2.2.101","volume":"2","author":"RC Pearson","year":"1989","unstructured":"Pearson RC, Powell TP (1989) The neuroanatomy of Alzheimer\u2019s disease. Rev Neurosci 2:101\u2013121","journal-title":"Rev Neurosci"},{"key":"67_CR46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1471-4159.1996.66020877.x","volume":"66","author":"E Sadot","year":"1996","unstructured":"Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, Fisher A (1996) Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem 66:877\u2013880","journal-title":"J Neurochem"},{"key":"67_CR47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"67_CR48","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.neurobiolaging.2005.07.010","volume":"27","author":"SW Tsang","year":"2006","unstructured":"Tsang SW, Lai MK, Kirvell S, Francis PT, Esiri MM, Hope T, Chen CP, Wong PT (2006) Impaired coupling of muscarinic M(1) receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer\u2019s disease. Neurobiol Aging 27:1216\u20131223","journal-title":"Neurobiol Aging"},{"key":"67_CR49","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.neurobiolaging.2006.06.001","volume":"28","author":"SW Tsang","year":"2007","unstructured":"Tsang SW, Pomakian J, Marshall GA, Vinters HV, Cummings JL, Chen CP, Wong PT, Lai MK (2007) Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer\u2019s disease. Neurobiol Aging 28:1381\u20131387","journal-title":"Neurobiol Aging"},{"key":"67_CR50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1124\/mol.104.003269","volume":"66","author":"EK Tung","year":"2004","unstructured":"Tung EK, Choi RC, Siow NL, Jiang JX, Ling KK, Simon J, Bernard EA, Tsim KW (2004) P2Y2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions. Mol Pharmacol 66:794\u2013806","journal-title":"Mol Pharmacol"},{"key":"67_CR51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237\u20131239","journal-title":"Science"},{"key":"67_CR52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cercor\/bhk012","volume":"17","author":"K Wirkner","year":"2007","unstructured":"Wirkner K, Gunther A, Weber M, Guzman SJ, Krause T, Fuchs J, Koles L, Norenberg W, Illes P (2007) Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cereb Cortex 17:621\u2013631","journal-title":"Cereb Cortex"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0067-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0067-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:25:09Z","timestamp":1559089509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,28]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0067-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1123064.580182","asserted-by":"object"}]},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,28]]}}}